tiprankstipranks
Trending News
More News >

Cardiff Oncology price target raised to $18 from $17 at H.C. Wainwright

H.C. Wainwright analyst Robert Burns raised the firm’s price target on Cardiff Oncology (CRDF) to $18 from $17 and keeps a Buy rating on the shares following the Q1 report.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1